-
1
-
-
0027448677
-
Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications
-
Warrell Jr RP. Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications. Blood 1993; 82: 1949-1953.
-
(1993)
Blood
, vol.82
, pp. 1949-1953
-
-
Warrell Jr., R.P.1
-
2
-
-
0036796742
-
Retinoic acid resistance in acute promyelocytic leukemia
-
Gallagher RE. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 2002; 16: 1940-1958.
-
(2002)
Leukemia
, vol.16
, pp. 1940-1958
-
-
Gallagher, R.E.1
-
3
-
-
0026040363
-
A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients
-
Chen Z-X, Xue Y-Q, Zhang R, Tao R-F, Xia X-M, Li C et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413-1419.
-
(1991)
Blood
, vol.78
, pp. 1413-1419
-
-
Chen, Z.-X.1
Xue, Y.-Q.2
Zhang, R.3
Tao, R.-F.4
Xia, X.-M.5
Li, C.6
-
4
-
-
0027517243
-
Resistance to all-trans-retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro sensitivity and cellular retinoic acid binding protein levels in leukemic cells
-
Delva L, Cornic M, Balitrand N, Guidez F, Miclea J-M, Delmer A et al. Resistance to all-trans-retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 1993; 82: 2175-2181.
-
(1993)
Blood
, vol.82
, pp. 2175-2181
-
-
Delva, L.1
Cornic, M.2
Balitrand, N.3
Guidez, F.4
Miclea, J.-M.5
Delmer, A.6
-
5
-
-
0032529284
-
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy
-
Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E et al. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood 1998; 92: 1172-1183.
-
(1998)
Blood
, vol.92
, pp. 1172-1183
-
-
Ding, W.1
Li, Y.P.2
Nobile, L.M.3
Grills, G.4
Carrera, I.5
Paietta, E.6
-
6
-
-
0037082488
-
Frequent mutations in the ligand binding domain of PML-RARα after multiple relapses of acute promyelocytic leukemia: Analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo
-
Zhou D-C, Kim S, Ding W, Schulz C, Warrell Jr RP, Gallagher RE. Frequent mutations in the ligand binding domain of PML-RARα after multiple relapses of acute promyelocytic leukemia: Analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood 2002; 99: 1356-1363.
-
(2002)
Blood
, vol.99
, pp. 1356-1363
-
-
Zhou, D.-C.1
Kim, S.2
Ding, W.3
Schulz, C.4
Warrell Jr., R.P.5
Gallagher, R.E.6
-
7
-
-
0032528520
-
Mutations in the E-domain of RARα portion of the PML/RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia
-
Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A et al. Mutations in the E-domain of RARα portion of the PML/RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. Blood 1998; 92: 374-382.
-
(1998)
Blood
, vol.92
, pp. 374-382
-
-
Imaizumi, M.1
Suzuki, H.2
Yoshinari, M.3
Sato, A.4
Saito, T.5
Sugawara, A.6
-
8
-
-
0034962358
-
Novel mutation in the PML/RARalpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia
-
Takayama N, Kizaki M, Hida T, Kinjo K, Ikeda Y. Novel mutation in the PML/RARalpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia. Exp Hematol 1998; 29: 864-872.
-
(1998)
Exp Hematol
, vol.29
, pp. 864-872
-
-
Takayama, N.1
Kizaki, M.2
Hida, T.3
Kinjo, K.4
Ikeda, Y.5
-
10
-
-
0034330993
-
Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia
-
Cote S, Zhou D, Bianchini A, Nervi C, Gallagher RE, Miller Jr WH. Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia. Blood 2000; 96: 3200-3208.
-
(2000)
Blood
, vol.96
, pp. 3200-3208
-
-
Cote, S.1
Zhou, D.2
Bianchini, A.3
Nervi, C.4
Gallagher, R.E.5
Miller Jr., W.H.6
-
11
-
-
0035525766
-
Invitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: A novel indicator of poor patient outcome
-
Cassinat B, Chevret S, Zassadowski F, Balitrand N, Guillemot I, Menot M-L et al. Invitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: A novel indicator of poor patient outcome. Blood 2001; 98: 2862-2864.
-
(2001)
Blood
, vol.98
, pp. 2862-2864
-
-
Cassinat, B.1
Chevret, S.2
Zassadowski, F.3
Balitrand, N.4
Guillemot, I.5
Menot, M.-L.6
-
12
-
-
0029940731
-
Infrequent alterations of the RARα gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines
-
Morosetti R, Grignani F, Liberatore C, Pelicci PG, Schiller GJ, Kizaki M et al. Infrequent alterations of the RARα gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood 1996; 87: 4399-4403.
-
(1996)
Blood
, vol.87
, pp. 4399-4403
-
-
Morosetti, R.1
Grignani, F.2
Liberatore, C.3
Pelicci, P.G.4
Schiller, G.J.5
Kizaki, M.6
-
13
-
-
0030992905
-
A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARα mutation
-
Shao W, Benedetti L, Lamph WW, Nervi C, Miller Jr WH. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARα mutation. Blood 1997; 89: 4282-4289.
-
(1997)
Blood
, vol.89
, pp. 4282-4289
-
-
Shao, W.1
Benedetti, L.2
Lamph, W.W.3
Nervi, C.4
Miller Jr., W.H.5
-
14
-
-
0030688916
-
Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: Differentiation induced by RA is triggered directly through PML-RARα and its down-reguation in acute promyelocytic leukemia
-
Kitamura K, Kiyoi H, Yoshida H, Saito H, Ohno R, Naoe T. Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARα and its down-reguation in acute promyelocytic leukemia. Leukemia 1997; 11: 1950-1956.
-
(1997)
Leukemia
, vol.11
, pp. 1950-1956
-
-
Kitamura, K.1
Kiyoi, H.2
Yoshida, H.3
Saito, H.4
Ohno, R.5
Naoe, T.6
-
15
-
-
0032148358
-
Targeting of PML/RARα is lethal to retinoic acid-resistant promyelocytic leukemia cells
-
Nason-Burchenal K, Allopenna J, Bégue A, Stéhelin D, Dmitrovsky E, Martin P. Targeting of PML/RARα is lethal to retinoic acid-resistant promyelocytic leukemia cells. Blood 1998; 92: 1758-1767.
-
(1998)
Blood
, vol.92
, pp. 1758-1767
-
-
Nason-Burchenal, K.1
Allopenna, J.2
Bégue, A.3
Stéhelin, D.4
Dmitrovsky, E.5
Martin, P.6
-
16
-
-
0036785378
-
Response to histone deacetylase inhibition of novel PML/RARalpha mutant detected in retinoic acid-resistant APL cells
-
Cote S, Rosenauer A, Bianchini A, Seiter K, Vandewiele J, Nervi C et al. Response to histone deacetylase inhibition of novel PML/RARalpha mutant detected in retinoic acid-resistant APL cells. Blood 2002; 100: 261-270.
-
(2002)
Blood
, vol.100
, pp. 261-270
-
-
Cote, S.1
Rosenauer, A.2
Bianchini, A.3
Seiter, K.4
Vandewiele, J.5
Nervi, C.6
-
17
-
-
0030923479
-
All-trans retinoic acid in acute promyelocytic leukemia
-
Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JE, Ogden A et al. All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021-1028.
-
(1997)
N Engl J Med
, vol.337
, pp. 1021-1028
-
-
Tallman, M.S.1
Andersen, J.W.2
Schiffer, C.A.3
Appelbaum, F.R.4
Feusner, J.E.5
Ogden, A.6
-
18
-
-
0038446666
-
Quantitative real-time RT-PCR analysis of PML-RARα mRNA in adult acute promyelocytic leukemia: Assessment of prognostic significance in adult patients from intergroup protocol 0129
-
Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S et al. Quantitative real-time RT-PCR analysis of PML-RARα mRNA in adult acute promyelocytic leukemia: Assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood 2003; 101: 2521-2528.
-
(2003)
Blood
, vol.101
, pp. 2521-2528
-
-
Gallagher, R.E.1
Yeap, B.Y.2
Bi, W.3
Livak, K.J.4
Beaubier, N.5
Rao, S.6
-
19
-
-
0035189081
-
Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARα mRNA using real-time reverse-transcription-PCR
-
Slack JL, Bi WB, Livak KJ, Beaubier N, Yu M, Clark M et al. Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARα mRNA using real-time reverse-transcription-PCR. J Mol Diagnost 2001; 3: 141-149.
-
(2001)
J Mol Diagnost
, vol.3
, pp. 141-149
-
-
Slack, J.L.1
Bi, W.B.2
Livak, K.J.3
Beaubier, N.4
Yu, M.5
Clark, M.6
-
20
-
-
0030812198
-
Association of PML-RARα fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: An intergroup molecular study
-
Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D et al. Association of PML-RARα fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: An intergroup molecular study. Blood 1997; 90: 1656-1663.
-
(1997)
Blood
, vol.90
, pp. 1656-1663
-
-
Gallagher, R.E.1
Willman, C.L.2
Slack, J.L.3
Andersen, J.W.4
Li, Y.P.5
Viswanatha, D.6
-
21
-
-
0001686739
-
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
-
Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J et al. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2002; 2: 117-125.
-
(2002)
Cancer Cell
, vol.2
, pp. 117-125
-
-
Shah, N.P.1
Nicoll, J.M.2
Nagar, B.3
Gorre, M.E.4
Paquette, R.L.5
Kuriyan, J.6
-
22
-
-
0036682481
-
Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment
-
Roche-Lestienne C, Soenen-Cornu V, Grardel-Duflos N, Lai J-L, Philippe N, Facon T et al. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. Blood 2002; 100: 1014-1018.
-
(2002)
Blood
, vol.100
, pp. 1014-1018
-
-
Roche-Lestienne, C.1
Soenen-Cornu, V.2
Grardel-Duflos, N.3
Lai, J.-L.4
Philippe, N.5
Facon, T.6
-
23
-
-
10744232328
-
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with poor prognosis
-
Branson S, Rudzki Z, Walsh S, Parkinson I, Grigg A, Szer J et al. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with poor prognosis. Blood 2003; 102: 276-283.
-
(2003)
Blood
, vol.102
, pp. 276-283
-
-
Branson, S.1
Rudzki, Z.2
Walsh, S.3
Parkinson, I.4
Grigg, A.5
Szer, J.6
-
24
-
-
0030061520
-
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: Evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse
-
Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: Evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse. Leukemia 1996; 10: 61-66.
-
(1996)
Leukemia
, vol.10
, pp. 61-66
-
-
Grimwade, D.1
Howe, K.2
Langabeer, S.3
Burnett, A.4
Goldstone, A.5
Solomon, E.6
-
25
-
-
0035525767
-
Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: Long-term follow-up in acute promyelocytic leukemia
-
Jurcic JG, Nimer SD, Scheinberg DA, DeBlasio T, Warrell Jr RP, Miller Jr WH. Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: Long-term follow-up in acute promyelocytic leukemia. Blood 2001; 98: 2651-2656.
-
(2001)
Blood
, vol.98
, pp. 2651-2656
-
-
Jurcic, J.G.1
Nimer, S.D.2
Scheinberg, D.A.3
DeBlasio, T.4
Warrell Jr., R.P.5
Miller Jr., W.H.6
-
26
-
-
24744443720
-
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: Correlation with clonal cytogenetic evolution but not response to therapy
-
Willis SG, Lange T, Demehri S, Otto S, Crossman L, Niedersieser D et al. High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: Correlation with clonal cytogenetic evolution but not response to therapy. Blood 2005; 106: 2128-2137.
-
(2005)
Blood
, vol.106
, pp. 2128-2137
-
-
Willis, S.G.1
Lange, T.2
Demehri, S.3
Otto, S.4
Crossman, L.5
Niedersieser, D.6
-
27
-
-
0033598931
-
A role for PML and the nuclear body in genomic stability
-
Zhong S, Hu P, Ye TZ, Stan R, Ellis NA, Pandolfi PP. A role for PML and the nuclear body in genomic stability. Oncogene 1999; 18: 7941-7947.
-
(1999)
Oncogene
, vol.18
, pp. 7941-7947
-
-
Zhong, S.1
Hu, P.2
Ye, T.Z.3
Stan, R.4
Ellis, N.A.5
Pandolfi, P.P.6
-
28
-
-
18244405576
-
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage
-
Salomoni P, Bernardi R, Bergmann S, Changou A, Tuttle S, Pandolfi PP. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage. Blood 2005; 105: 3686-3690.
-
(2005)
Blood
, vol.105
, pp. 3686-3690
-
-
Salomoni, P.1
Bernardi, R.2
Bergmann, S.3
Changou, A.4
Tuttle, S.5
Pandolfi, P.P.6
-
29
-
-
0038527642
-
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor
-
Di Croce L, Raker VA, Corsaro M, Faxi F, Fanelli M, Faretta M et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002; 295: 1079-1082.
-
(2002)
Science
, vol.295
, pp. 1079-1082
-
-
Di Croce, L.1
Raker, V.A.2
Corsaro, M.3
Faxi, F.4
Fanelli, M.5
Faretta, M.6
-
30
-
-
17044401059
-
Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia
-
Sanz MA, Tallman MS, Lo-Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood 2005; 105: 3019-3025.
-
(2005)
Blood
, vol.105
, pp. 3019-3025
-
-
Sanz, M.A.1
Tallman, M.S.2
Lo-Coco, F.3
-
31
-
-
4644293319
-
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
-
Lo-Coco F, Cimino G, Breccia M, Noguera NI, Diverio D, Finolezzi E et al. Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia. Blood 2004; 104: 1995-1999.
-
(2004)
Blood
, vol.104
, pp. 1995-1999
-
-
Lo-Coco, F.1
Cimino, G.2
Breccia, M.3
Noguera, N.I.4
Diverio, D.5
Finolezzi, E.6
-
32
-
-
0035145435
-
All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia
-
Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 2001; 38: 13-25.
-
(2001)
Semin Hematol
, vol.38
, pp. 13-25
-
-
Fenaux, P.1
Chomienne, C.2
Degos, L.3
-
33
-
-
21744462100
-
Dynamics of chronic myeloid leukaemia
-
Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL et al. Dynamics of chronic myeloid leukaemia. Nature 2005; 435: 1267-1270.
-
(2005)
Nature
, vol.435
, pp. 1267-1270
-
-
Michor, F.1
Hughes, T.P.2
Iwasa, Y.3
Branford, S.4
Shah, N.P.5
Sawyers, C.L.6
-
34
-
-
22144443475
-
Drug resistance in cancer: Principles of emergence and prevention
-
Komarova NL, Wodarz D. Drug resistance in cancer: Principles of emergence and prevention. Proc Natl Acad Sci USA 2005; 102: 9714-9719.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 9714-9719
-
-
Komarova, N.L.1
Wodarz, D.2
-
35
-
-
21744437143
-
Predicting the effect of transcription therapy in hematologic malignancies
-
Melnick A. Predicting the effect of transcription therapy in hematologic malignancies. Leukemia 2005; 19: 1109-1117.
-
(2005)
Leukemia
, vol.19
, pp. 1109-1117
-
-
Melnick, A.1
|